Literature DB >> 10795028

The Diabetic Foot.

.   

Abstract

Management of foot problems in the patient with diabetes mellitus requires attention to each system affected by the disease. Appropriate treatment of common clinical problems affecting the foot in diabetic patients, such as ulcerations and fractures, depends on a thorough understanding of the pathophysiology of the disease. Treatment of neuropathy is directed at pressure relief and prevention of deformity. Infection is addressed with antibiotics, debridement, and improvement of the vascularity and oxygenation of the tissues. Amputation should be viewed, not as evidence of treatment failure, but as a reconstructive procedure, the goal of which is to regain energy-efficient ambulation. The orthopaedic surgeon can play a critical role in the team approach to the care of the diabetic patient with foot problems.

Entities:  

Year:  1995        PMID: 10795028     DOI: 10.5435/00124635-199507000-00004

Source DB:  PubMed          Journal:  J Am Acad Orthop Surg        ISSN: 1067-151X            Impact factor:   3.020


  3 in total

1.  Topical Phenytoin Application in Grade I and II Diabetic Foot Ulcers: A Prospective Study.

Authors:  Vijaya Patil; Rashmi Patil; P L Kariholu; L S Patil; Praveeen Shahapur
Journal:  J Clin Diagn Res       Date:  2013-10-05

2.  Radiographic and functional results in the treatment of early stages of Charcot neuroarthropathy with a walker boot and immediate weight bearing.

Authors:  Maria Candida Ribeiro Parisi; Alexandre Leme Godoy-Santos; Rafael Trevisan Ortiz; Rafael Barban Sposeto; Marcos Hideyo Sakaki; Marcia Nery; Tulio Diniz Fernandes
Journal:  Diabet Foot Ankle       Date:  2013-10-29

3.  Outcome after protected full weightbearing treatment in an orthopedic device in diabetic neuropathic arthropathy (Charcot arthropathy): a comparison of unilaterally and bilaterally affected patients.

Authors:  Niklas Renner; Stephan Hermann Wirth; Georg Osterhoff; Thomas Böni; Martin Berli
Journal:  BMC Musculoskelet Disord       Date:  2016-12-29       Impact factor: 2.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.